Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

14 results about "Proteome profiling" patented technology

Proteome Profiling. Characterization of proteins from organisms, their body fluids or extracts is the main aim of Proteome profiling. Thus profiling of a proteome serves as a foundation for the study of quantitative changes and modification of the targeted proteins.

Methods and applications for constructing a target proteome atlas

The application relates to a method for constructing a target proteome spectrum library and application in micro target proteome analysis, and the method comprises the following steps: performing multiple times of mass spectrum scanning on a target proteome in a data-dependent acquisition mode without dynamic exclusion through different scanning ranges, so as to obtain mass spectrum data of the target proteome, wherein the mass spectrum data of the target proteome comprises primary spectra of multiple scanning ranges of the target proteome and secondary spectra of parent ions in each scanning range, which meet a preset threshold; and performing library searching based on the mass spectrum data of the target proteome to construct the target proteome spectrum library. The application constructs a spectrum library through mass spectrum data in a data-dependent acquisition mode without dynamic exclusion in multiple scanning ranges, performs library searching analysis on DIA data of a micro proteome, improves the success rate of DIA data matching, and further improves the accuracy and sensitivity of DIA data analysis, and improves the accuracy and sensitivity of micro protein identification.
Owner:REPRODUCTIVE & GENETIC HOSPITAL OF CITIC XIANGYA CO LTD +1

Identification, quantitation and analysis of unique biomarkers in sweat

ActiveUS12672799B2MedicineProteomic Profile
A biomarker diagnostic system includes a sensor to collect a sweat sample from a biological subject; a processor operatively connected to the sensor, wherein the processor is configured to perform metabolic and proteomic profiling of biomarkers in the sweat sample. The metabolic and proteomic profile is compared to a predetermined profile of the biomarkers and to determine a physiological status of the biomarkers. The system further includes a feedback unit operatively coupled to the sensor and the processor and configured to output physiological performance data based on the physiological status.
Owner:THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE

Target, biomarker, and patient selection discovery methods using cell-type specific spatial proteomics and machine learning

PCT designated stageWO2026030628A3Nervous system cellsOmicsAbzymePatient stratification
Methods for target, biomarker, and patient selection discovery in central nervous system disorders utilizing patient-derived cellular models, spatial proteomics, and machine learning. The method generates neural cells from forebrain regions from induced pluripotent stem cells, performs cell-type specific proteome profiling using antibody-enzyme conjugates and spatial proteome profiling, and applies statistical data augmentation to sparse biological datasets. Machine learning classifiers with SHAP-based feature importance identify ranked biomarkers from mass spectrometry data. The platform enables patient stratification by linking molecular signatures to symptom severity, drug screening through biomarker modulation, and diagnostic applications. Kits comprising antibodies for biomarkers including antibodies for biomarkers identified by the method facilitate implementation. Applications include autism spectrum disorder, rare neurodevelopmental disorders, schizophrenia, epilepsy, Alzheimer's disease, and Parkinson's disease.
Owner:HEBBIAN BIO INC

Quantitative shotgun proteome, lipidome, and metabolome analysis by direct infusion

The present invention provides methods and systems using gas-phase separation with mass spectrometry analysis instead of liquid chromatography, thereby enabling faster peptide, proteome, and multi-omic analysis. Also provided are improved methods and software for data independent acquisition. One embodiment referred to as Direct Infusion-Shotgun Proteome Analysis (DI-SPA) used with data-independent acquisition mass spectrometry (DIA-MS), resulted in targeted quantification of over 500 proteins within minutes of MS data collection (˜3.5 proteins / second). Enabling fast, unbiased protein and proteome quantification without liquid chromatography, DI-SPA offers a new approach to boosting throughput critical to drug and biomarker discovery studies that require analysis of thousands of proteomes. This invention is also able to perform complex multi-omic analysis of proteomes, lipidomes, and metabolomes on a single platform.
Owner:MEDICAL COLLEGE OF WISCONSIN INC +1

Fishing broad-spectrum vibrio oral vaccine based on reverse vaccinology as well as preparation method and application of fishing broad-spectrum vibrio oral vaccine

The invention relates to the technical field of disease prevention and control in aquaculture, in particular to a fishery broad-spectrum vibrio oral vaccine based on reverse vaccinology as well as a preparation method and application of the fishery broad-spectrum vibrio oral vaccine. Specifically, on the basis of a reverse vaccinology technology, generic proteome analysis is carried out on common pathogenic vibrios in fish culture, and protein with homology is screened. Through comprehensive analysis of key factors such as subcellular localization, antigenicity, immunogenicity and adhesion, candidate antigens with high potential are further screened out. On the basis, an immunoinformatics method is utilized to carry out epitope prediction analysis on candidate antigens, peptide fragments rich in high-density epitopes are screened out, and the multi-epitope recombinant antigen oral vaccine taking bacillus subtilis as a carrier is constructed according to the peptide fragments. The oral delivery efficiency is enhanced by adopting an alginate microencapsulation process, and feeding of sebastes schlegeli shows that the vaccine has an excellent immune effect, can be used for anti-vibrio drugs, and has a good practical application value.
Owner:SHANDONG UNIV +1

Congored derivatives photocatalytic probes, methods of making and using same

The present application relates to the technical field of Congo red derivative photocatalytic probe application, and particularly relates to a Congo red derivative photocatalytic probe, a preparation method and a use method thereof, comprising a compound I, the compound I is selected from at least one of the Congo red derivative photocatalytic probes, and the Congo red derivative photocatalytic probe comprises two arene, the arene represents an aromatic heterocycle, and the aromatic heterocycle is selected from one of a benzene ring, furan, thiophene and a naphthalene ring. The Congo red derivative photocatalytic probe provided by the present application can specifically label amyloid plaques in AD brain tissue slices, the binding affinity is significantly improved (Kd of Aβ 1‑40 The Congo red derivative photocatalytic probe can reveal the molecular heterogeneity of amyloid deposition and the key regulatory role of the mitochondrial autophagy-lysosome axis, provide a new tool for AD pathological mechanism research, support proteomic analysis and pathological mechanism analysis across brain regions (hippocampus / cortex), and protect the molecular structure and application in the research of neurodegenerative diseases.
Owner:THE SECOND HOSPITAL OF DALIAN MEDICAL UNIV

Lipid droplet targeted photosensitive fluorescent molecule, preparation method and application

PendingCN121930221AGood lipid droplet targetingincrease photosensitivityOrganic chemistryFluorescence/phosphorescenceIntracellularLipid Body
The invention discloses a lipid droplet targeted photosensitive fluorescent molecule as well as a preparation method and application thereof. The fluorescent molecule has a structure as shown in a formula I, wherein R is selected from at least one of a formula a, a formula b, a formula c, a formula d, a formula e and a formula f; according to the application, the lipid droplet targeting and photosensitivity of fluorescent molecules are utilized to realize proximity labeling of proteins around lipid droplets in cells, and regulatory factors of interaction of the lipid droplets and mitochondria are disclosed through proteome analysis. The probe realizes proximity markers which do not depend on genetic manipulation in the field.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Tandem-trapped ion mobility spectrometry with microarray and biosensor

Disclosed is an analytical platform for profiling and functional analysis of proteomes, which can unveil new biological insights potentially useful for instigating novel therapeutic interventions. The disclosed analytical platform for proteome profiling is constructed by integrating plasmonic biosensor microarrays with tandem-ion mobility spectrometry. The disclosed analytical platform can separate, identify, and characterize highly similar proteoforms as well as low abundance proteoforms from plasma or other samples.
Owner:FLORIDA STATE UNIV RES FOUND INC

Target, biomarker, and patient selection discovery methods using cell-type specific spatial proteomics and machine learning

PCT designated stageWO2026030628A2Nervous system cellsOmicsAbzymePatient stratification
Methods for target, biomarker, and patient selection discovery in central nervous system disorders utilizing patient-derived cellular models, spatial proteomics, and machine learning. The method generates neural cells from forebrain regions from induced pluripotent stem cells, performs cell-type specific proteome profiling using antibody-enzyme conjugates and spatial proteome profiling, and applies statistical data augmentation to sparse biological datasets. Machine learning classifiers with SHAP-based feature importance identify ranked biomarkers from mass spectrometry data. The platform enables patient stratification by linking molecular signatures to symptom severity, drug screening through biomarker modulation, and diagnostic applications. Kits comprising antibodies for biomarkers including antibodies for biomarkers identified by the method facilitate implementation. Applications include autism spectrum disorder, rare neurodevelopmental disorders, schizophrenia, epilepsy, Alzheimer's disease, and Parkinson's disease.
Owner:HEBBIAN BIO INC

Tandem-trapped ion mobility spectrometry with microarray and biosensor

PCT designated stageWO2026080740A1Peptide librariesMaterial analysis by electric/magnetic meansFunctional profilingBlood plasma
Disclosed is an analytical platform for profiling and functional analysis of proteomes, which can unveil new biological insights potentially useful for instigating novel therapeutic interventions. The disclosed analytical platform for proteome profiling is constructed by integrating plasmonic biosensor microarrays with tandem-ion mobility spectrometry. The disclosed analytical platform can separate, identify, and characterize highly similar proteoforms as well as low abundance proteoforms from plasma or other samples.
Owner:FLORIDA STATE UNIV RES FOUND INC

Quantitative shotgun proteome, lipidome, and metabolome analysis by direct infusion

The present invention provides methods and systems using gas-phase separation with mass spectrometry analysis instead of liquid chromatography, thereby enabling faster peptide, proteome, and multi-omic analysis. Also provided are improved methods and software for data independent acquisition. One embodiment referred to as Direct Infusion—Shotgun Proteome Analysis (DI-SPA) used with data-independent acquisition mass spectrometry (DIA-MS), resulted in targeted quantification of over 500 proteins within minutes of MS data collection (˜3.5 proteins / second). Enabling fast, unbiased protein and proteome quantification without liquid chromatography, DI-SPA offers a new approach to boosting throughput critical to drug and biomarker discovery studies that require analysis of thousands of proteomes. This invention is also able to perform complex multi-omic analysis of proteomes, lipidomes, and metabolomes on a single platform.
Owner:WISCONSIN ALUMNI RES FOUND +1

A method for proteomic analysis and a substrate prepared for the method

PCT designated stageWO2026077489A1Preparing sample for investigationBiological testingProteomics methodsAntigen binding
The invention relates to a method for proteomic analysis and a substrate prepared for the method. The substrate is prepared with immobilized antibodies using the electrospray deposition method, where a planar conductive plate is used as the substrate, onto which ions of immunoglobulin-binding protein are deposited by electrospray, then at least one antibody with affinity for the target antigen is dispensed onto the substrate with immobilized immunoglobulin-binding protein, which is anchored via a non-covalent affinity interaction with the immobilized immunoglobulin-binding protein. Subsequently, a sample containing the antigen is dispensed onto the substrate with the immobilized immunoglobulin-binding protein and bound antibody, and the prepared substrate is incubated. After incubation of the substrate, sample residues are removed, an analyte with an antigen is chemically reduced or eluted from the substrate and cleaved with trypsin, an analyte with an antigen is desalted, and the sample is analysed using a proteomic method.
Owner:MIKROBIOLOGICKY USTAV AV CR V V I

Method for multi-omics exploration of regulation mechanism of duckweed protein content under environmental stress

The invention provides a method for multi-omics exploration of a regulation mechanism of duckweed protein content under environmental stress, and belongs to the technical field of protein regulation, target duckweed is firstly pretreated, and then corresponding environmental stress treatment is performed on the target duckweed after pretreatment, and the method is characterized in that crude protein content is measured on the target duckweed after the environmental stress treatment, and the content of protein in the target duckweed is measured; the method comprises the following steps: selecting a treatment group and a control group with significant phenotype difference according to a crude protein content determination result, carrying out transcriptome sequencing and proteome analysis, carrying out bioinformatics analysis on data of transcriptome sequencing and proteome analysis, and obtaining a regulation mechanism; the method can comprehensively, deeply and accurately reveal the internal molecular regulation mechanism of the duckweed responding to environmental stress and accumulating protein, so that a more accurate and suitable culture strategy can be obtained according to the regulation mechanism, and the protein content of the duckweed can be greatly increased.
Owner:LINGNAN MODERN AGRI SCI & TECH GUANGDONG PROVINCIAL LAB HEYUAN BRANCH CENT

A method, device and computer software for preparing a liquid protein sample for proteome analysis

A method of preparing a liquid protein sample for proteome analysis comprising: pumping a liquid protein sample into a heated tubing, wherein the liquid protein sample comprises a plurality of portion
Owner:THERMO FISHER SCI BREMEN